Cargando…
Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
Patients with type 2 diabetes mellitus (T2DM) are at increased risk of severe coronavirus disease 2019 (COVID-19) outcomes possibly because of dysregulated inflammatory responses. Glucose-regulating medications, such as glucagon-like peptide 1 receptor (GLP-1R) agonists, dipeptidyl peptidase 4 (DPP-...
Autores principales: | Nyland, Jennifer E., Raja-Khan, Nazia T., Bettermann, Kerstin, Haouzi, Philippe A., Leslie, Douglas L., Kraschnewski, Jennifer L., Parent, Leslie J., Grigson, Patricia Sue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660979/ https://www.ncbi.nlm.nih.gov/pubmed/34580086 http://dx.doi.org/10.2337/db21-0385 |
Ejemplares similares
-
Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes: A 6-Year Cohort Study
por: Ricks, Joni, et al.
Publicado: (2012) -
Cause-Specific Mortality Trends in a Large Population-Based Cohort With Long-Standing Childhood-Onset Type 1 Diabetes
por: Secrest, Aaron M., et al.
Publicado: (2010) -
Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016) -
The Neuropathic Diabetic Foot Ulcer Microbiome Is Associated With Clinical Factors
por: Gardner, Sue E., et al.
Publicado: (2013) -
Topical Prostaglandin E Analog Restores Defective Dendritic Cell–Mediated Th17 Host Defense Against Methicillin-Resistant Staphylococcus Aureus in the Skin of Diabetic Mice
por: Dejani, Naiara N., et al.
Publicado: (2016)